Home Tags Genetics
genetics Related Content
Richie Kohman, Synthetic Biology Platform Lead at the Wyss Institute for Biologically Inspired Engineering discusses his work on Next Generation Sequencing within biological tissues The Synthetic Biology Platform at the Wyss Institute is innovating the use of Next Generation Sequencing (NGS) to study intact biological tissues. NGS is one of...
Ute Deichmann of the Jacques Loeb Centre for the History and Philosophy of the Life Sciences at Ben-Gurion University, explores the role hierarchical causal models have on constancy and plasticity in biology.
Here, we find out about Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic.
Dr Jen Vanderhoven, Director, National Horizons Centre, Teesside University, sheds some light on how the gene therapy field can progress in the face of funding challenges and skills shortages.
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
Associate Professor Ken Tachibana, discloses how prenatal ambient fine particle exposure disrupts DNA methylation and subsequent gene expression in the foetal development stage.
Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.
Scientists in France have partially restored the eyesight of a blind man, using gene therapy - he is now able to identify blurry shapes.
Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
Professor Olivier Braissant is at the University Hospital of Lausanne (CHUV) - he works on rare genetic diseases impacting brain development.
Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
When it comes to the impact of evolution on different face shapes and features, scientists have long been looking to identify the genes involved - now, researchers at University College London believe they have an answer.
John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.
New research published in the British Journal of Psychiatry suggests that parents caring for disabled children are at risk of mental health issues
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
Professor Darren Griffin and Dr Rebecca O’Connor from the University of Kent’s School of Biosciences, discuss their work on improving UK pig production and reaching out to South East Asia.
PTC Therapeutics have announced the use of a blood test for the rare genetic condition, aromatic L-amino acid decarboxylase (AADC) deficiency.
12Page 1 of 2